Junya Ohtake

IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells

Yosuke Ohno, Hidemitsu Kitamura, Norihiko Takahashi et al. · Cancer Immunology Immunotherapy · 2016 · 110 citations · Full text

Inflammation, Human Dendritic Cells, Autoimmune Disease +9

First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer‐hybrid epitope long peptide of MAGE‐A4 cancer antigen

Norihiko Takahashi, Takayuki Ohkuri, Shigenori Homma et al. · Cancer Science · 2012 · 60 citations · Full text

Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti‐PD‐1 inhibitor

Norikazu Matsuo, Koichi Azuma, Satoshi Hattori et al. · International Journal of Cancer · 2018 · 38 citations · Full text

Soluble Immune Mediators, Immunology, Immune Regulation +19

IL-11 induces differentiation of myeloid-derived suppressor cells through activation of STAT3 signalling pathway

Kentaro Sumida, Yosuke Ohno, Junya Ohtake et al. · Scientific Reports · 2015 · 30 citations · Full text

Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine

Junya Ohtake, Takayuki Ohkuri, Yuji Togashi et al. · Immunology Letters · 2014 · 28 citations

Vaccination, Vaccine Target, Survivin Cancer-associated Antigen +9